Satellite Symposium to the ASGT Annual Meeting

ASGT 年会卫星研讨会

• 批准号: 7159941
• 负责人: James M Wilson
• 金额: $ 1万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-05-01 至 2007-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7159941
• 关键词: gene therapy; meeting /conference /symposium; transfection /expression vector; travel

The goal of this program is to provide partial support of a satellite symposium in conjunction with the 2006 meeting of the American Society of Gene Therapy (ASGT). Meeting. This symposium would be held as an evening session during the ASGT meeting which is scheduled for May 31-June 4, 2006. The provisional title for the symposium is: ? AAV and Lentivirus Vectors: Integration and Insertional Mutagenesis? Currently there are plans for six speakers, for approximately 20 minutes each, followed by a panel discussion involving the presenters who would take questions from the audience. Each of the speakers has been chosen because his/her research findings are relevant to the principal topics of the symposium. The field of gene therapy has undergone tremendous evolution over the last fifteen years. Many studies presented in previous gene therapy meetings were primarily descriptive. As the field has evolved recently, the barriers to its successful development have been defined and many scientists have focused on studying the basic biology that underlies these limitations. As an important scientific organization, the American Society for Gene Therapy (ASGT) has set a continuing goal for its ninth annual meeting. The scientific program is designed to address those developments in basic cell and molecular biology that provide the essential infrastructure for the ultimate emergence of gene therapy as a major therapeutic discipline in the field of medicine. The meeting topics that will be covered include: stem cells, nonviral vectors, regulatable vectors, adenoviral, retroviral, and episomal vectors, the immune response, genetic diseases, atherosclerosis, skeletal muscle and CNS disorders, AIDS, and cancer. This meeting differs from that of many others in the area of gene therapy in that it encompasses both scientific and educational goals, and has a known capacity to attract an international audience. This application to the National Institute of Diabetes and Digestive and Kidney Diseases is for support of the AAV and Lentivirus Vectors: Integration and Insertional Mutagenesis Symposia.

该计划的目标是为卫星研讨会提供部分支持 与 2006 年美国基因治疗学会 (ASGT) 会议同时举行。 会议。本次研讨会将在 ASGT 期间作为晚间会议举行 会议定于 2006 年 5 月 31 日至 6 月 4 日举行。临时名称为 研讨会是： ？ AAV 和慢病毒载体：整合和插入诱变？ 目前计划有 6 名发言人，每人约 20 分钟，随后 通过由演讲者参加的小组讨论，演讲者将回答来自与会者的问题 观众。选择每位演讲者是因为他/她的研究成果是 与本次研讨会的主要议题相关。 过去十五年来，基因治疗领域经历了巨大的发展。 之前的基因治疗会议上提出的许多研究主要是描述性的。 随着该领域最近的发展，其成功发展的障碍已经出现 定义，许多科学家专注于研究其背后的基础生物学 这些限制。作为一个重要的科学组织，美国基因学会 Therapy (ASGT) 为其第九届年会设定了持续目标。科学的 该计划旨在解决基础细胞和分子生物学的这些发展 为基因治疗作为一种治疗方法的最终出现提供了必要的基础设施 医学领域的主要治疗学科。会议主题将是 涵盖包括：干细胞、非病毒载体、可调节载体、腺病毒、逆转录病毒、 和游离载体、免疫反应、遗传疾病、动脉粥样硬化、骨骼 肌肉和中枢神经系统疾病、艾滋病和癌症。这次会议与许多次会议不同 基因治疗领域的其他领域，因为它涵盖科学和教育 目标，并具有吸引国际观众的已知能力。此应用程序至 国家糖尿病、消化和肾脏疾病研究所支持 AAV 和慢病毒载体：整合和插入诱变研讨会。